购物车
- 全部删除
- 您的购物车当前为空
JB061是一种非肌肉肌球蛋白II抑制剂,针对心肌肌球蛋白、骨骼肌肌球蛋白和平滑肌肌球蛋白II的IC50分别为4.4 μM、9.1 μM和>100 μM。其对ATP酶活性的抑制作用较弱(IC50>200 μM)。此外,JB061对COS-7细胞显示出细胞毒性,IC50值为39 μM。
为众多的药物研发团队赋能,
让新药发现更简单!
JB061是一种非肌肉肌球蛋白II抑制剂,针对心肌肌球蛋白、骨骼肌肌球蛋白和平滑肌肌球蛋白II的IC50分别为4.4 μM、9.1 μM和>100 μM。其对ATP酶活性的抑制作用较弱(IC50>200 μM)。此外,JB061对COS-7细胞显示出细胞毒性,IC50值为39 μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 329 | 现货 | |
5 mg | ¥ 738 | 现货 | |
10 mg | ¥ 1,120 | 现货 | |
25 mg | ¥ 1,990 | 现货 | |
50 mg | ¥ 2,990 | 现货 | |
100 mg | ¥ 4,580 | 现货 | |
500 mg | ¥ 9,570 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 819 | 现货 |
产品描述 | JB061 is a nonmuscle myosin inhibitor, demonstrating selective inhibitory activity with IC50 values of 4.4 μM (Cardiac muscle myosin), 9.1 μM (Skeletal muscle myosin), and >100 μM (Smooth muscle myosin II). It exhibits limited efficacy in reducing ATPase activity, with an IC50 exceeding 200 μM. Furthermore, JB061 displays cytotoxic effects on COS-7 cells, evidenced by an IC50 value of 39 μM. |
靶点活性 | Skeletal muscle myosin:rabbit, Smooth muscle myosin II:>100 μM, Cardiac muscle myosin:4.4 μM |
体外活性 | N-acetyl-D-Lactosamine (10 microg/ml) was a potent mitogen towards human peripheral blood mononuclear cells.[3] N-acetyl-D-Lactosamine (100 microg/ml) has 50% growth inhibitory potential towards SiHa (human cervix ) cancer cell line.[3] |
分子量 | 323.34 |
分子式 | C19H17NO4 |
Smiles | COc1cccc(C\N=C(/C)c2c(O)c3ccccc3oc2=O)c1 |
密度 | no data available |
存储 | Shipping with blue ice. | ||||||||||||||||||||
溶解度信息 | DMSO: 4 mg/mL (12.37 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容